Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Surmodics Inc (SRDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 987,900
  • Shares Outstanding, K 13,350
  • Annual Sales, $ 73,110 K
  • Annual Income, $ 3,930 K
  • 36-Month Beta 0.72
  • Price/Sales 13.30
  • Price/Cash Flow 75.80
  • Price/Book 8.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year 0.18
  • Growth Rate Est. (year over year) -105.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.82 +4.48%
on 09/21/18
82.35 -10.14%
on 09/04/18
-0.15 (-0.20%)
since 08/24/18
3-Month
53.75 +37.67%
on 06/28/18
82.35 -10.14%
on 09/04/18
+18.45 (+33.21%)
since 06/22/18
52-Week
25.00 +196.00%
on 02/09/18
82.35 -10.14%
on 09/04/18
+43.95 (+146.26%)
since 09/22/17

Most Recent Stories

More News
Intuitive Surgical and InTouch Collaborate for IoMT Services

Intuitive Surgical's (ISRG) IoMT likely to benefit patients; market prospects impressive.

AAPL : 219.86 (-0.42%)
SRDX : 74.00 (+1.65%)
MASI : 123.82 (+1.08%)
ISRG : 569.27 (+2.25%)
3 Top Stocks From the Booming US Medical Products Industry

The U.S. Medical Products industry is sturdy on solid focus on technological advancement.

SRDX : 74.00 (+1.65%)
ATHN : 133.14 (-2.53%)
VEEV : 105.40 (+0.25%)
ICUI : 271.15 (+2.13%)
QDEL : 64.17 (-1.03%)
GW Pharmaceuticals (GWPH) Catches Eye: Stock Jumps 5.9%

GW Pharmaceuticals (GWPH) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

SRDX : 74.00 (+1.65%)
GWPH : 171.22 (+2.82%)
Medical - Products Stock Outlook: Short-Term Pain Inevitable

Medical - Products Stock Outlook: Short-Term Pain Inevitable

ABT : 71.98 (+0.76%)
SRDX : 74.00 (+1.65%)
ICUI : 271.15 (+2.13%)
QDEL : 64.17 (-1.03%)
Here's Why You Should Invest in Surmodics (SRDX) Stock Now

Continuous focus on R&D and a raised guidance for fiscal 2018 make Surmodics (SRDX) a lucrative pick for investors.

SRDX : 74.00 (+1.65%)
ATHN : 133.14 (-2.53%)
MASI : 123.82 (+1.08%)
ISRG : 569.27 (+2.25%)
Baxter's Actifuse Flow Bone Graft Substitute Gets FDA Nod

The latest FDA approval for Baxter's (BAX) Actifuse Flow bone graft is likely to boost its Advanced Surgery segment.

SRDX : 74.00 (+1.65%)
EGRX : 68.69 (+1.93%)
BAX : 77.75 (+0.49%)
ICUI : 271.15 (+2.13%)
Why Is SurModics (SRDX) Up 19.9% Since Last Earnings Report?

SurModics (SRDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SRDX : 74.00 (+1.65%)
Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries

Zacks.com highlights: Buckle, Illumina, Surmodics and Huntington Ingalls Industries

SRDX : 74.00 (+1.65%)
ILMN : 360.20 (+0.54%)
HII : 253.97 (-0.68%)
BKE : 22.80 (+0.44%)
Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International

Zacks.com highlights: Illumina, Vertex Pharmaceuticals, Surmodics and McDermott International

SRDX : 74.00 (+1.65%)
ILMN : 360.20 (+0.54%)
VRTX : 184.00 (+1.00%)
MDR : 18.39 (-0.59%)
4 Winning Stocks With Solid Efficiency Level

A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.

SRDX : 74.00 (+1.65%)
ILMN : 360.20 (+0.54%)
VRTX : 184.00 (+1.00%)
MDR : 18.39 (-0.59%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Trade SRDX with:

Business Summary

SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring...

See More

Key Turning Points

2nd Resistance Point 75.97
1st Resistance Point 74.98
Last Price 74.00
1st Support Level 72.93
2nd Support Level 71.87

See More

52-Week High 82.35
Last Price 74.00
Fibonacci 61.8% 60.44
Fibonacci 50% 53.67
Fibonacci 38.2% 46.91
52-Week Low 25.00

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar